Combination vaccines

MD Decker - Primary Care: Clinics in Office Practice, 2001 - primarycare.theclinics.com
The present rapid growth in the availability of safe and effective vaccines provides a
continuing need to expand and simplify vaccine administration programs. The replacement …

Burden of whooping cough in China (PertussisChina): study protocol of a prospective, population-based case–control study

J Yu, H He, Y Zhang, Y Gao, C Chen, J Xu, L Xu… - BMJ open, 2022 - bmjopen.bmj.com
Introduction Pertussis is one of the top 10 diseases of children under 10 years of age, and
the few vaccine-preventable diseases who is on a rise in China in recent years; however …

Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China

X Pan, H Lv, H Liang, Y Wang, L Shen… - Human Vaccines & …, 2022 - Taylor & Francis
Objectives The aim of this study is to describe the reporting rate of adverse events following
immunization (AEFI) with pentavalent vaccine: diphtheria-pertussis-tetanus-poliomyelitis …

Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b …

Y Li, RC Li, Q Ye, C Li, YP Liu, X Ma, Y Li… - Human Vaccines & …, 2017 - Taylor & Francis
We conducted 3 phase III, randomized, open-label, clinical trials assessing the safety,
reactogenicity (all studies), immunogenicity (Primary vaccination study) and persistence of …

[HTML][HTML] 国内外儿童用联合疫苗免疫原性, 安全性和社会价值

刘翰谕, 魏霞, 赵天朔, 韩冰峰, 刘贝, 杨莉… - 中华流行病学 …, 2021 - html.rhhz.net
联合疫苗含有两种或多种抗原, 研究认为接种联合疫苗后能预防多种疾病, 同时可减少接种次数.
本文对国内外儿童用联合疫苗, 如无细胞百白破疫苗(DTaP), 麻疹-风疹-腮腺炎疫苗(MMR) …

[HTML][HTML] 预防接种知情告知专家共识(下)

Chinese Preventive Medicine Association - 中华流行病学杂志, 2021 - html.rhhz.net
《 中华人民共和国疫苗管理法》 和其他相关法律法规对受种者或其监护人的疫苗和预防接种工作
知情提出了要求, 对预防接种告知方式和内容作出了规定. 本共识以该法和《 预防接种工作规范》 …

[HTML][HTML] 预防接种知情告知专家共识(上)

Chinese Preventive Medicine Association - 中华流行病学杂志, 2021 - html.rhhz.net
《 中华人民共和国疫苗管理法》 和其他相关法律法规对受种者或其监护人的疫苗和预防接种工作
知情提出了要求, 对预防接种告知方式和内容作出了规定. 本共识以该法和《 预防接种工作规范》 …

无细胞百白破b 型流感嗜血杆菌联合疫苗不同部位接种安全性及免疫原性评价

刘振江, 吴春敏, 黄家梅, 叶素贞, 吴惠华, 周翔… - 中国公共卫生, 2022 - zgggws.com
无细胞百白破b 型流感嗜血杆菌联合疫苗不同部位接种安全性及免疫原性评价 Page 1 • 流行病学
研究 • 无细胞百白破b 型流感嗜血杆菌联合疫苗不同 部位接种安全性及免疫原性评价 刘振江1,吴 …

[HTML][HTML] Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model

X Wang, N Gao, J Wen, J Li, Y Ma, M Sun, J Liang… - Vaccines, 2021 - mdpi.com
The research and development of a pertussis-combined vaccine using a novel inactivated
poliovirus vaccine made from the Sabin strain (sIPV) is of great significance in the polio …

Safety and immunogenocity of a novel combined Haemophilus influenzae type b–Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in …

J Hu, H Tao, J Li, W Dai, B Song, J Sun… - Human Vaccines & …, 2015 - Taylor & Francis
A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and
C-tetanus-toxoid conjugate vaccine (Hib-MenAC vaccine) has been developed to protect …